Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-6-29
pubmed:abstractText
A variety of acyl derivatives based on the "antedrug" concept were synthesized to evaluate their biological activities, in vitro fate in human serum and examine pharmacokinetics in rats. Among the prepared compounds, acetyl and pivaloyl derivatives (8 and 9) showed strong to vasoconstrictive activity in human, exceeding that of dexamethasone. In rats, topical administration of the compound 8 significantly reduced oxazolone-induced ear edema compared to that of control. These activities were almost equal to that of prednisolone, however 9 did not show any suppression of the oxazolone-induced edema. The in vitro half-lives of 8 and 9 in human serum were 18.2 and 43.8 hours, respectively. Prednisolone and dexamethasone were extremely stable under the used conditions. When compound 8 was intravenously administrated to rats, its metabolites, 20(R)-methyl dexamethasonate (4) and carboxylic acid (18), were found in the systemic blood. The total body clearance of 8 was 1734 ml x hr(-1) x kg(-1), which was about 12 times larger than that of dexamethasone. On the other hand, 9 was found to be metabolized instantaneously to methyl prednisolonate (1) in systemic serum. Acetyl derivative 8 derived from dexamethasone may thus be useful as a topical steroid which offers the advantage of a low potential for systemic and local side effects.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0040-8727
pubmed:author
pubmed:issnType
Print
pubmed:volume
187
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
127-40
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10228984-Administration, Topical, pubmed-meshheading:10228984-Adult, pubmed-meshheading:10228984-Animals, pubmed-meshheading:10228984-Blood Vessels, pubmed-meshheading:10228984-Dexamethasone, pubmed-meshheading:10228984-Ear Diseases, pubmed-meshheading:10228984-Edema, pubmed-meshheading:10228984-Female, pubmed-meshheading:10228984-Glucocorticoids, pubmed-meshheading:10228984-Glycolates, pubmed-meshheading:10228984-Half-Life, pubmed-meshheading:10228984-Humans, pubmed-meshheading:10228984-Male, pubmed-meshheading:10228984-Mice, pubmed-meshheading:10228984-Mice, Inbred Strains, pubmed-meshheading:10228984-Middle Aged, pubmed-meshheading:10228984-Prednisolone, pubmed-meshheading:10228984-Rats, pubmed-meshheading:10228984-Rats, Sprague-Dawley, pubmed-meshheading:10228984-Skin, pubmed-meshheading:10228984-Steroids, pubmed-meshheading:10228984-Vasoconstrictor Agents
pubmed:year
1999
pubmed:articleTitle
Examination on biological activities and fates of new steroids, steroid-17-yl methyl glycolate derivatives.
pubmed:affiliation
Department of Pharmaceutical Science, Akita University Hospital, Japan. suzuki@yakari.hos.akit-u.ac.jp
pubmed:publicationType
Journal Article